Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: Results of a six‐month, multicenter, randomized, double‐blind, controlled, phase IV trial

Braun, J.; Kästner, P.; Flaxenberg, P.; Währisch, J.; Hanke, P.; Demary, W.; von Hinüber, U.; Rockwitz, K.; Heitz, W.; Pichlmeier, U.; Guimbal‐Schmolck, C.; Brandt, A.; Study Group, MC‐MTX.6/RH

doi:10.1002/art.23144

Public

Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: Results of a six‐month, multicenter, randomized, double‐blind, controlled, phase IV trial

Shared by NobleBlocks on Dec 28, 2007 • 12:00 AM UTC

Authors:

J. Braun

P. Kästner

P. Flaxenberg

Abstract

Abstract Objective To compare the efficacy and safety of subcutaneous (SC) versus oral administration of methotrexate (MTX) in patients with active rheumatoid arthritis (RA). Methods MTX‐naive patients with active RA (Disease Activity Score in 28 joints ≥4) were eligible for the study if they had no...

Discussions